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Abstract
Background: Human resources for health are at a critical low. The World Health Organization estimates that the
current shortage of health workers, including pharmacists, is in excess of 7.2 million worldwide and that, by 2035,
the shortage will reach 12.9 million. Pharmacists, in particular, are lacking in the workforce in many countries. The
International Pharmaceutical Federation (FIP) and academic partners have conducted periodic global pharmacy
workforce surveys in 2006, 2009 and 2012 which have monitored and reported on the status of the pharmacy
workforce at the country and territory levels. This current analysis is a synthesis of workforce capacity data from
these date points to provide an overview of the global trends and changes to pharmacy workforce capacity over
this time period.
Methods: The methodology proceeded with accessing workforce capacity data collated in 2006, 2009 and 2012
held on file at the FIP Collaborating Centre. This data had previously been validated and made available to WHO
Human Resources for Health. The data focused (due to limitations from 2006 databank) on pharmacist workforce
capacity. Countries and territories were identified that had data available across at least two of the three time
points (2006, 2009 and 2012). Missing time-point data for some countries (data gaps) were subject, where possible,
to literature and online data searching to capture possible missing data. Country-level capacity data were plotted
against time to identify trends coupled with comparative analysis of the trends.
Results: The countries and territories identified as having valid data for each of the time points 2006, 2009 and
2012 were present in all WHO regions, with Europe having the most countries with data available and South East
Asia the fewest.
All WHO regions have experienced an increase in the density of pharmacists (measured as number of pharmacists
per 10 000 population) over the period 2006–2012. However, some countries show a reduction in the density of
pharmacists. African countries show large relative increases in acceleration of capacity building but remain
significantly behind in terms of absolute capacity per capita. South East Asian and Middle Eastern countries also
show large proportional changes in pharmacist workforce.
Conclusion: The global trend is an increase in workforce across all nations and regions, and this is a move in the right
direction towards improved access to, and availability of, pharmaceutical expertise. However, there is still much to be
done, with some regions and low-income countries still displaying a disproportionately low number of pharmacists on
small overall capacity for delivering pharmacy services.
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Background
Human resources for health are at a critical low. The
World Health Organization estimates that the current
shortage of health workers, including pharmacists, is in
excess of 7.2 million worldwide and that, by 2035, the
shortage will reach over 13 million [1]. Pharmacists,1 in
particular, are lacking in the workforce in many
countries. In addition, education and training needs to
be strengthened globally.
The International Pharmaceutical Federation (FIP)
Global Pharmacy Workforce surveys conducted in 2006
[2], 2009 [3] and 2012 [4] analysed, monitored and re-
ported on the status of the pharmacy workforce at the
country and territory levels. In 2012, the survey collected
workforce data for 90 countries and territories represent-
ing 2.5 million pharmacists and nearly one and a half mil-
lion technicians and support workers. Fifty-six countries
responded to the 2009 report and 34 to the 2006 survey.
A key message from the 2006, 2009 and 2012 Global
Pharmacy Workforce reports was that pharmacy work-
force density varied considerably between countries and
WHO regions and generally correlated with population
numbers and country-level economic development
indicators. Those countries and territories with lower
economic indicators tended to have relatively fewer
pharmacists and pharmacy technicians. With the recent
launch of global pharmaceutical workforce development
goals (WDGs: http://www.fip.org/educationreports), FIP
have highlighted that workforce intelligence is a critical
factor in planning for transformative change; under-
standing the global trends in workforce capacity, in
addition to the absolute capacity values, adds an import-
ant dimension to policy planning.
Access to high-quality health services is vital for the
delivery of a nation’s positive health outcomes. For ex-
ample, the reduction of morbidity associated with long-
term conditions requires access to pharmacy teams who
can provide medicines and services, to ensure their
responsible use. Ensuring the availability of an appropri-
ately skilled pharmacy workforce within services and
facilities with effective distribution across a nation is an
important approach for improving equitable access. Each
country and territory in this report started from a differ-
ent baseline in terms of the number of pharmacists. The
impact of changes in the density of the pharmacy work-
force (whether this is an increase or decrease) on health
outcomes is difficult to judge. Additionally, changing
epidemiology and disease burden at a country level as
well as population increases need to be considered and
an assessment made as to whether the development of
pharmacy human resources has adapted and made an
impact over time.
The proportion of women in the pharmacy workforce
continues to increase resulting in more part-time
working and therefore a greater headcount being re-
quired to meet demand. Productivity of pharmacists in
many locations is being increased due to technology
(use of robotics) and optimising skill mix (supported by
changing scope of the pharmacy technician role) [5].
Conversely, demand for pharmacists is also increasing in
some areas because of the creation of new roles in order
to mitigate shortages in other healthcare professions
such as medicine and nursing.
Policy developments from WHO Human Resources
for Health clearly indicate current and projected chronic
shortages of the healthcare workforce and the availability
of a skilled pharmacy workforce for access to expertise
and essential medicines has been made clear [6, 7]. The
objective of this paper is to describe the key issues and
current trends affecting the global pharmacy workforce
by providing a synthesis of the changes to pharmacy
workforce capacity over the time period covering 2006,
2009 and 2012. In particular, the data provides a focus
on workforce distribution over time, to provide better
intelligence on trends in capacity by country.
Methods
The methodology proceeded with accessing workforce
capacity data collated in 2006, 2009 and 2012 held on
file at the FIP Collaborating Centre (see references [2–4]).
The data focused (due to limitations from 2006 databank)
on pharmacist workforce capacity. Countries and territor-
ies were identified that had data available across at least
two of the three time points (2006, 2009 and 2012). Miss-
ing time-point data for some countries (data gaps) were
subject, where possible, to literature and online data
searching to capture possible missing data. Country-level
capacity data were plotted against time to identify trends
coupled with comparative analysis of the trends. Work-
force capacity is measured as ‘density’ which is the num-
ber pharmacists per 10 000 population, and serves as a
standardised measure for the purposes of this report.
The base workforce capacity data for years 2006, 2009
and 2012 were collated from repeat surveys of national
agencies (professional leadership bodies, health work-
force regulators, ministries) and conducted by the FIP
Collaborating Centre, University College London, School
of Pharmacy and the FIP Education directorate (FIPEd).
The collated data related to pharmacy workforce
capacity and was available in English, French and Spanish.
Surveys had been conducted using email contacts derived
from FIP, website information with repeat follow-up for
non-responders. This data had previously been validated
and made available to WHO Human Resources for Health
[8]. Gaps in the date-stamped data were identified and lit-
erature and web searches were conducted where possible
to minimise data gaps. The aim was to have three valid,
date-stamped data points per country; for a small minority
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of countries in this sample, only two date points were able
to be used.
Additional country-level variables included national
population (as reported by the World Bank for each date
stamp), pharmacist registries, and national demographic
data such as Gross National Income & Expenditure
(World Bank data repositories). A full methodology on
the FIP survey process and data validation has been pre-
viously reported [8].
A combined dataset of national workforce capacity
was constructed that captured data at the three date
points (2006, 2009, 2012 contiguous cases). This new
dataset was cleaned and prepared for analysis using SPSS
Statistics v22. Limitations include a reliance, for some
data coordinates, on published data and secondary
sources for national data (rather than drawn from the
FIP Survey method). Quality assurance was based on
previous reporting and identification of data outliers for
cross-checking. A fuller methodology has been previ-
ously reported [8].
Results
Matching data across the three time points (2006, 2009,
2012) and charting pharmacist capacity across these
dates provides an overview as seen in Fig. 1 compared
across aggregated WHO regional groups of countries.
Figure 1 illustrates both the mean percentage change in
pharmacist density for each WHO region and also the
important absolute change in pharmacist density per
capita. The data comprises 58 countries with at least two
date points (out of three) and 50 countries with all three
date points (2006, 2009, 2012) in total representing
around 30% of current WHO member states.
Charting the change in workforce density over the
period 2006–2012 provides a meaningful picture of
workforce capacity trends. The full sample (n = 58 coun-
tries) is shown in Fig. 2a; countries and territories are
identified by the ISO three-letter abbreviation (see Add-
itional file 1 for alphabetic order) to maintain clarity.
The cluster of countries at the bottom of Fig. 2a are
those that have very low pharmacist densities and due to
scaling of the vertical axis cannot easily be identified on
this chart; Fig. 2b shows this cluster in expanded scale
detail for comparison. Figure 3 shows relative changes
(trends) in workforce capacity between 2006 and 2012
for individual countries with validated date points (data
standardised using Z-scores for graphical scaling). As
can be seen, for some countries, capacity has reduced
during this time period.
The workforce density data was also examined by
country-level income classification (World Bank) and
presented as Figs. 4 and 5 for individual countries in the
sample. Figure 6 shows the aggregated capacity change
(as absolute density) across the time period using World
Fig. 1 Change in absolute capacity by WHO region (units are number pharmacists/10 000 population) from 2006 to 2012. Percent figures in
brackets indicate the mean proportional change in density from 2006 baseline (N = 50 countries)
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Fig. 2 a Time trend for full data sample 2006–2012. b Time trend for low capacity data cases (data sub-set of a)
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Bank income level classification. Figure 6 also shows that
an increased capacity trend is more prevalent in higher-
income countries and is associated with economic
factors as measured by World Bank income status.
There is a significant association between absolute
change in capacity (over time) and country-level higher-
income status (Spearman’s rho = 0.419, p = 0.002). Al-
though some African nations, for example, have made
significant relative increases in capacity development
(Uganda and Sudan have increased their own capacity
by high percentages) in relation to other countries in ab-
solute terms, Africa remains capacity-poor overall.
Discussion
The countries and territories identified as having data
for each of the time points 2006, 2009 and 2012 were
present in all the WHO regions, with Europe having the
most countries with data available and South East Asia
the fewest. All WHO regions have experienced an
increase in the density of pharmacists per 10 000 popu-
lation over the period 2006–2012. Some decreases
observed in density of pharmacists may be a result of
net migration to other countries or other factors such
as changes in national health policy. The negative ef-
fects on workforce supply of health worker migration
and lack of supportive policy action, for example in
providing quality educational infrastructure, has been
documented [9].
Although the density of pharmacists has increased
substantially in many lower-income countries such as
Ethiopia, their baseline still remains low compared with
those of higher-income countries. For both lower-
income countries and higher-income countries, overall
workforce numbers should be determined by strategic
goals set by health policy-makers considering demand
for health services. However, in reality reaching these
goals may be challenging because of variations in the
production of the workforce (e.g. numbers of schools of
pharmacy and the lag time between educating and
deploying staff ) leaving lower-income countries with
chronically low numbers in comparison with higher-
income countries. Other influences that contribute to
the dynamics of the workforce are the flows of pharma-
cists into and out of countries (immigration and emigra-
tion), part-time/interrupted practice and the proportion
of workers reaching retirement age—all of these impact
on the number of pharmacists available to nations.
We have shown changes in pharmacist capacity over
the three time points of this study, displayed as an ‘abso-
lute’ change in pharmacist density per capita, and
additionally as relative percent change. It is important to
clarify that percentage changes and absolute changes may
Fig. 3 Relative capacity change as a Z-score (N = 50 country cases from 2006 to 2012)
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tell different stories. A small change in the absolute
pharmacist density in a country with very low capacity to
begin with can result in a large percentage increase; con-
versely, a small percentage increase in a country with high
density will result in a large absolute figure for workforce
headcount. Within the WHO regions, there are also signifi-
cantly wide variances that can make interpretation of aggre-
gate statistics difficult. However, it is clear that the global
trend for pharmacist workforce is increasing, and based on
these data presented here, we estimate this increase to have
been around 16% over the period concerned.
Again, converting changes to relative proportional
changes may mask small absolute trends, particularly in
smaller nations or nations with low capacity to begin
with, with African nations having the smallest absolute
changes in capacity. However, in this data set, not all
countries have shown an increase in capacity, although
changes in overall population denominators may con-
tribute to the negative increases. The data also shows
that some countries with small initial capacity (for ex-
ample Sudan, Uganda) have a relative proportionally
increased capacity, although once again their absolute
capacity density remains very low in comparison with
other, often more high-income, countries.
When considering changes in the density of pharma-
cists per country over time, it is useful to consider what
the effect is on pharmacy workforce balance. When
there is a national ‘gap’ between supply and demand for
the pharmacy workforce, then imbalances occur.
Variations in pharmacist density should not necessarily
be considered a workforce imbalance. Changes may also
reflect differences in role as pharmacists may be contrib-
uting to a nation’s healthcare in non-patient facing roles
in the pharmaceutical industry and pharmaceutical
manufacturing units. Additionally, density of pharma-
cists does not describe the productivity or distribution
(and therefore accessibility, as generally healthcare
workers tend to be more concentrated in urban rather
than rural areas) of the workforce.
For instance, as health demand increases, the health-
care workforce needs to shift either by increasing its
supply or by increases in its productivity. Absolute
Fig. 4 Time trend for low and lower middle income data cases 2006–2012
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numbers of pharmacists do not reflect the issue of part-
time workers, especially if their proportion has a greater
increase relative to the growth in the number of phar-
macists [8]. Failure to respond to increased health
demand results in workforce imbalances and risks non-
achievement of positive health outcomes.
Mapping pharmacists per capita with the World Bank
classification gives an indication of the relationship of
the workforce with economic indicators. Global
Pharmacy Workforce Reports have shown a linear associ-
ation with total pharmacist numbers and World Bank
classification. In other words, the higher the level of a
country’s income, the greater the number of pharmacists.
Fig. 5 Time trend for high and upper middle income data cases 2006–2012
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Figure 6 illustrates that the capacity change over the
period 2006–2012 (i.e. the change in the mean num-
ber of pharmacists per 10 000 population) showed
the largest increase for the upper-middle-income
countries compared with all other country income
groups. This may reflect a greater increase in the
growth in the economies classified as upper-middle
income compared with other country income groups.
Funding of the pharmacy workforce will also have an
effect on its national workforce density.
Presenting data on workforce is always problematic, as
has been alluded to earlier in this paper. For those coun-
tries where there were only two data points rather than
three, the impact on workforce trends is less reliable. Like-
wise, data sourced from the web and literature searches
may not be viewed as valid compared to that which was
previously collated and validated from surveys. Presenting
proportional change (which is easier to visualise) or
absolute change (harder to interpret but more realistic) is
challenging. Other limitations include the lack of direct
association between capacity as a measure and whether
there is a sufficient supply of pharmacists with the
relevant competencies and skill mix. For countries with
already low densities of pharmacists, it is possible that
there is a gap between the need for pharmacy services and
the actual supply of pharmacists.
Conclusions
Although many WHO regions have experienced in-
creases in their pharmacist workforce (notably the
Eastern Mediterranean and Africa) over the period
2006–2012, countries and territories that are classified
by the World Bank as low or lower middle income still
have a low density of pharmacists compared with those
nations classified as high or upper middle income [8]. It
has been well documented that for low-income countries
in particular there is a shortage of healthcare profes-
sionals needed to deal with the local disease burden.
Such countries’ increases in workforce (where they can
be achieved) might not be keeping pace with the in-
creases in population and shifts in disease burden.
It is essential to monitor the global pharmacist work-
force trends at regular time points so that decisions can
be made as to how countries can deploy their workforce.
Fig. 6 Capacity change (density) for World Bank-classified countries
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Endnotes
1“Pharmacist” is defined in this paper as a licenced,
regulated and/or registered health care professional, with
accredited and regulated degree-entry initial education
and training. We are not including data on pharmacy
technicians, or pharmacy assistants, in this analysis.
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